{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T03:42:00Z","timestamp":1779939720576,"version":"3.53.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T00:00:00Z","timestamp":1518652800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,1]]},"DOI":"10.1093\/jac\/dky005","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T12:12:22Z","timestamp":1515413542000},"page":"1167-1172","source":"Crossref","is-referenced-by-count":61,"title":["Primary resistance to integrase strand transfer inhibitors in patients infected with diverse HIV-1 subtypes in sub-Saharan Africa"],"prefix":"10.1093","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0155-7391","authenticated-orcid":false,"given":"Seth C","family":"Inzaule","sequence":"first","affiliation":[{"name":"Department of Global Health, Academic Medical Center of the University of Amsterdam, and Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands"},{"name":"Joep Lange Institute, Department of Global Health, Academic Medical Centre of the University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raph L","family":"Hamers","sequence":"additional","affiliation":[{"name":"Department of Global Health, Academic Medical Center of the University of Amsterdam, and Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands"},{"name":"Eijkman-Oxford Clinical Research Unit, Jakarta, Indonesia, and Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Noguera-Julian","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit & IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Universitat Aut\u00f2noma de Barcelona, Badalona, Catalonia, Spain"},{"name":"Universitat de Vic-Universitat Central de Catalunya, C. Sagrada Fam\u00edlia 7, 08500 Vic, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Casadell\u00e0","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit & IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Universitat Aut\u00f2noma de Barcelona, Badalona, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariona","family":"Parera","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit & IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Universitat Aut\u00f2noma de Barcelona, Badalona, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias F","family":"Rinke de Wit","sequence":"additional","affiliation":[{"name":"Department of Global Health, Academic Medical Center of the University of Amsterdam, and Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands"},{"name":"Joep Lange Institute, Department of Global Health, Academic Medical Centre of the University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Paredes","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit & IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Universitat Aut\u00f2noma de Barcelona, Badalona, Catalonia, Spain"},{"name":"Universitat de Vic-Universitat Central de Catalunya, C. Sagrada Fam\u00edlia 7, 08500 Vic, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,2,14]]},"reference":[{"key":"key\n\t\t\t\t20180420055449_dky005-B1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/01.JAA.0000475465.07971.19","article-title":"HIV pharmacotherapy: a review of integrase inhibitors","volume":"29","author":"Wong","year":"2016","journal-title":"JAAPA"},{"key":"key\n\t\t\t\t20180420055449_dky005-B2","author":"DHHS","year":"2016"},{"key":"key\n\t\t\t\t20180420055449_dky005-B3","author":"(EACS) EACS","year":"2017"},{"key":"key\n\t\t\t\t20180420055449_dky005-B4","author":"World Health Organization","year":"2016"},{"key":"key\n\t\t\t\t20180420055449_dky005-B5","author":"World Health Organization","year":"2017"},{"key":"key\n\t\t\t\t20180420055449_dky005-B6","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/QAD.0000000000001494","article-title":"Emergent drug resistance with integrase strand transfer inhibitor-based regimens","volume":"31","author":"Lepik","year":"2017","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180420055449_dky005-B7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/cid\/cit697","article-title":"Resistance to HIV integrase strand transfer inhibitors among clinical specimens in the United States, 2009-2012","volume":"58","author":"Hurt","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180420055449_dky005-B8","doi-asserted-by":"crossref","first-page":"36.","DOI":"10.1186\/s12977-017-0360-7","article-title":"HIV drug resistance against strand transfer integrase inhibitors","volume":"14","author":"Anstett","year":"2017","journal-title":"Retrovirology"},{"key":"key\n\t\t\t\t20180420055449_dky005-B9","first-page":"17","article-title":"Characterization and structural analysis of HIV-1 integrase conservation","volume":"11","author":"Ceccherini-Silberstein","year":"2010","journal-title":"AIDS Rev"},{"key":"key\n\t\t\t\t20180420055449_dky005-B10","doi-asserted-by":"crossref","first-page":"74.","DOI":"10.1186\/1742-4690-5-74","article-title":"Natural variation of HIV-1 group M integrase: implications for a new class of antiretroviral inhibitors","volume":"5","author":"Rhee","year":"2008","journal-title":"Retrovirology"},{"key":"key\n\t\t\t\t20180420055449_dky005-B11","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1097\/QAD.0b013e32833cf265","article-title":"HIV-1 subtype B and C integrase enzymes exhibit differential patterns of resistance to integrase inhibitors in biochemical assays","volume":"24","author":"Bar-Magen","year":"2010","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180420055449_dky005-B12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/135965350901400108","article-title":"Genetic barriers for integrase inhibitor drug resistance in HIV type-1 B and CRF02_AG subtypes","volume":"14","author":"Ma\u00efga","year":"2009","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20180420055449_dky005-B13","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1128\/JVI.03353-14","article-title":"Differential effects of the G118R, H51Y, and E138K resistance substitutions in different subtypes of HIV integrase","volume":"89","author":"Quashie","year":"2015","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180420055449_dky005-B14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.meegid.2016.06.047","article-title":"Differences among HIV-1 subtypes in drug resistance against integrase inhibitors","volume":"46","author":"Han","year":"2016","journal-title":"Infect Genet Evol"},{"key":"key\n\t\t\t\t20180420055449_dky005-B15","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/jac\/dkw071","article-title":"Development of a G118R mutation in HIV-1 integrase following a switch to dolutegravir monotherapy leading to cross-resistance to integrase inhibitors","volume":"71","author":"Brenner","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180420055449_dky005-B16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/ije\/dyq192","article-title":"Cohort profile: the PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance\u2014HIV drug resistance in sub-Saharan Africa and the Asia-Pacific","volume":"41","author":"Hamers","year":"2012","journal-title":"Int J Epidemiol"},{"key":"key\n\t\t\t\t20180420055449_dky005-B17","first-page":"132","article-title":"2017 Update of the drug resistance mutations in HIV-1","volume":"24","author":"Wensing","year":"2017","journal-title":"Top Antivir Med"},{"key":"key\n\t\t\t\t20180420055449_dky005-B18","author":"INSTI Resistance Mutation Scores"},{"key":"key\n\t\t\t\t20180420055449_dky005-B19"},{"key":"key\n\t\t\t\t20180420055449_dky005-B20","author":"World Health Organization"},{"key":"key\n\t\t\t\t20180420055449_dky005-B21","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1128\/AAC.01492-10","article-title":"Analysis of low-frequency mutations associated with drug resistance to raltegravir before antiretroviral treatment","volume":"55","author":"Liu","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180420055449_dky005-B22","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/QAD.0b013e3283367796","article-title":"High frequency of integrase Q148R minority variants in HIV-infected patients naive of integrase inhibitors","volume":"24","author":"Charpentier","year":"2010","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180420055449_dky005-B23","author":"Mutation Prevalence According to Subtype and Treatment"},{"key":"key\n\t\t\t\t20180420055449_dky005-B24","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/jac\/dkv333","article-title":"Deep analysis of HIV-1 natural variability across HIV-1 variants at residues associated with integrase inhibitor (INI) resistance in INI-naive individuals","volume":"71","author":"Ll\u00e1cer Delicado","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180420055449_dky005-B25","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1093\/jac\/dkq319","article-title":"Mutation Q95K enhances N155H-mediated integrase inhibitor resistance and improves viral replication capacity","volume":"65","author":"Fun","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180420055449_dky005-B26","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/jac\/dkw109","article-title":"Polymorphic substitution E157Q in HIV-1 integrase increases R263K-mediated dolutegravir resistance and decreases DNA binding activity","volume":"71","author":"Anstett","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180420055449_dky005-B27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cmi.2015.10.004","article-title":"Contribution of APOBEC3G\/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variants","volume":"22","author":"Noguera-Julian","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180420055449_dky005-B28","doi-asserted-by":"crossref","first-page":"1506.","DOI":"10.1093\/ofid\/ofw172.1208","article-title":"Two reported cases of only primary integrase inhibitor drug-class resistance transmission including the first reported case of primary elvitegravir resistance transmission","volume":"3","author":"Hsu","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"key\n\t\t\t\t20180420055449_dky005-B29","doi-asserted-by":"crossref","first-page":"35779.","DOI":"10.1038\/srep35779","article-title":"Prevalence of integrase strand transfer inhibitors (INSTI) resistance mutations in Taiwan","volume":"6","author":"Chang","year":"2016","journal-title":"Sci Rep"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/5\/1167\/24610052\/dky005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T23:50:39Z","timestamp":1660261839000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/5\/1167\/4859670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,14]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,2,14]]},"published-print":{"date-parts":[[2018,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dky005","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,5]]},"published":{"date-parts":[[2018,2,14]]}}}